Patients who are admitted with an ST-segment elevated myocardial infarction (STEMI) undergo primary percutaneous coronary intervention (PCI) as soon as possible. Currently, over 95% of STEMI patients who do not present with shock survive the initial phase. Ronak Delewi’s research focuses on the possible complications that survivors are then faced with and also investigates the effects of intracoronary bone marrow cell therapy on STEMI outcomes.
R. Delewi: Percutaneous Coronoray Interevention in Acute Myocardial Infarction.
Prof. F.J. Zijlstra (Erasmus MC)
Prof. J.J. Piek
Prof. J.G.P Tijssen
Dr A. Hirsch (RUG)
This event is open to the public.